ANE
MÍNGUEZ OLAONDO
Instituto de Investigación Sanitaria Aragón
Zaragoza, EspañaInstituto de Investigación Sanitaria Aragón-ko ikertzaileekin lankidetzan egindako argitalpenak (7)
2024
-
Nueva era terapéutica para el ataque de migraña con los recientemente aprobados anticuerpos monoclonales, ditanes y gepantes
Revista de neurologia, Vol. 78, Núm. 2, pp. 47-57
-
Visual snow syndrome in patients with migraine: widening the clinical spectrum of the syndrome with permanent and episodic manifestations
Neurological Sciences, Vol. 45, Núm. 9, pp. 4437-4444
2023
-
Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry
Journal of Headache and Pain, Vol. 24, Núm. 1
-
Telemedicine in the management of patients with headache: current situation and recommendations of the Spanish Society of Neurology's Headache Study Group
Neurologia, Vol. 38, Núm. 9, pp. 635-646
2022
-
Cutaneous Allodynia in Migraine: A Narrative Review
Frontiers in Neurology, Vol. 12
-
Dysautonomia in COVID-19 Patients: A Narrative Review on Clinical Course, Diagnostic and Therapeutic Strategies
Frontiers in Neurology, Vol. 13
-
Nummular headache responsive to anti-calcitonin gene-related peptide monoclonal antibodies in a patient with migraine
Headache, Vol. 62, Núm. 8, pp. 1063-1066